Skip to content
10-K

Annual Report

KEDEM PHARMACEUTICALS INC.

0001493152-12-001153

← back to feed
Filed
Aug 28, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Aug 28, 2012 18.19M sh
Operating Cash Flow FY 2012 · May 31, 2012 −$1.94M
Operating Cash Flow FY 2012 · May 31, 2012 −$4.55M
Operating Cash Flow FY 2012 · May 31, 2011 −$1.44M
Cash And Equivalents FY 2012 · May 31, 2012 $294.94K
Cash And Equivalents FY 2012 · May 31, 2011 $1.49M
Cash And Equivalents FY 2012 · May 31, 2010 $1.05M
Stockholders Equity FY 2012 · May 31, 2012 −$3.28M
Stockholders Equity FY 2012 · May 31, 2011 $584.69K
Stockholders Equity FY 2012 · May 31, 2009 $281.74K
Current Liabilities FY 2012 · May 31, 2012 $4.4M
Current Liabilities FY 2012 · May 31, 2011 $2.13M
Current Assets FY 2012 · May 31, 2012 $416.67K
Current Assets FY 2012 · May 31, 2011 $1.53M
Total Assets FY 2012 · May 31, 2012 $1.12M
Total Assets FY 2012 · May 31, 2011 $2.71M
Sga Expense FY 2012 · May 31, 2012 $382.33K
Sga Expense FY 2012 · May 31, 2012 $955.42K
Sga Expense FY 2012 · May 31, 2011 $273.08K
Rd Expense FY 2012 · May 31, 2012 $846.47K
Rd Expense FY 2012 · May 31, 2012 $2.03M
Rd Expense FY 2012 · May 31, 2011 $664.5K
Net Income FY 2012 · May 31, 2012 −$5.91M
Net Income FY 2012 · May 31, 2012 −$12.37M
Net Income FY 2012 · May 31, 2011 −$4.17M
Net Income FY 2012 · May 31, 2010 −$2.18M
Net Income FY 2012 · May 31, 2009 −$173.26K
Operating Income FY 2012 · May 31, 2012 −$2.35M
Operating Income FY 2012 · May 31, 2012 −$6.51M
Operating Income FY 2012 · May 31, 2011 −$2.04M